Bright.md, the leading health care delivery automation company, unveiled product enhancements for optimized patient-centric care for its award-winning asynchronous virtual care platform, SmartExam.
“As the physician capacity shortage continues to impact the industry, health care organizations are challenged to serve more patients than they can see in a day. Patients who are frustrated at delays in care often just look for another provider. In response, many organizations are implementing digital strategies that enhance their ability to attract and retain patients, and stay competitive,” said Dr. Ray Costantini, CEO and co-founder of Bright.md. “But a digital front door that leads to nowhere creates more problems than it solves. What practices really need is an automated point of entry that can help them treat everyone more effectively, and more efficiently, while lifting the burden that’s been put on the doctors.”
Key enhancements to SmartExam are focused on improving care delivery and enhancing provider workflow integration, ensuring that SmartExam continues to provide a seamless patient and provider experience. Innovations include:
- Smart Care Pathways™ — Care escalation for critical scenarios
- Care Advisor™ — Simplified guided interviews at point of entry
- Configurable Formularies — Customized for system preferences
- Inclusive Design — Greater accessibility for health equity among diverse patient populations
- Security Assurance — SOC2 data compliance
“At Presbyterian, we believe useful innovation is a building block of health care,” said Dr. Ries Robinson, chief innovation officer at Presbyterian Healthcare Services. “Bright.md’s dedication to that shared value is reflected in the ways they continue to improve their offerings and propel health care forward.”
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Carrum Health, the first cloud-based platform connecting employers and employees with Centers of Excellence (COE) for surgical procedures, has announced a new partnership with Rothman Orthopaedic Institute, a world-leader in orthopaedic care, as its newest Center of Excellence. The partnership is the latest milestone in Carrum Health’s aggressive nationwide expansion plan, making it easier for self-insured employers in the New York, New Jersey, and Pennsylvania areas to provide top-quality, affordable healthcare benefits to employees and their dependents.
“As a quality and value leader in orthopaedics, Rothman Orthopaedics meets the strict quality standards against which we measure all potential COE providers,” said Christoph Dankert, vice president of Product at Carrum Health. “Current and prospective Fortune 500 employer customers in the region are excited about the addition of an internationally-recognized leader in orthopedics, and we’re looking forward to growing the market together with Rothman Orthopaedics. We are especially excited because this anticipates Carrum’s entry into the Greater New York and Greater Philadelphia markets.”
“The partnership with Carrum Health strengthens our direct-to-employer channel and will allow us to tap into the rapidly growing Center of Excellence market with Carrum Health as our trusted partner,” said Mike West, CEO of Rothman Orthopaedic Institute. “We are excited about bringing Rothman Orthopaedics’ unique model for orthopaedic excellence and value to Carrum Health’s employer customers and every member on their plans.”
The partnership gives as many as 100,000 members in the tri-state area access to one of the leading orthopaedic providers in the country within a drive of under two hours. The alliance also expands Carrum Health’s footprint into New York, New Jersey, and Pennsylvania areas and paves the way for the upcoming expansion of Carrum’s sports medicine program.
X-37 has raised $14.5 million in a Series A round. The new funding will be used to help expand the number of drug development programs. To read more, click here.
Remedy Analytics analyzes the data produced by pharmacy benefit managers (to help organizations lower their pharmaceutical spending. To read more, click here.
Are you a healthcare startup raising money next year, available April 21-22 and open to traveling to Chicago? Consider applying for our Pitch Perfect competition at INVEST. Click here for details.
Picture: akindo, Getty Images
